South Cone Investments Limited Partnership

CIK: 0001876412

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)4 (100.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

RANI

Rani Therapeutics Holdings, Inc.

10% Owner

Discretionary Trading P&L

Holdings

Transaction History (4 total)

RANI
Rani Therapeutics Holdings, Inc.
Oct 21, 2025
Sale(S)
Indirect
4M shares at avg. $2.77$11.1M
RANI
Rani Therapeutics Holdings, Inc.
Oct 20, 2025
Sale(S)
Indirect
1.9M shares at avg. $2.41$4.6M
RANI
Rani Therapeutics Holdings, Inc.
Oct 15, 2024
Sale(S)
Indirect
3.3M shares at avg. $2.55$8.4M
RANI
Rani Therapeutics Holdings, Inc.
Oct 15, 2024
Sale(S)
Indirect
523.7K shares at avg. $3.26$1.7M

		Type	Shares	Price		Ownership
Oct 21, 2025	RANI Rani Therapeutics Holdings, Inc.	Sale(S)	4,000,000	$2.77	$11,074,000	Indirect
Oct 20, 2025	RANI Rani Therapeutics Holdings, Inc.	Sale(S)	1,923,000	$2.41	$4,637,315	Indirect
Oct 15, 2024	RANI Rani Therapeutics Holdings, Inc.	Sale(S)	3,305,622	$2.55	$8,436,278	Indirect
Oct 15, 2024	RANI Rani Therapeutics Holdings, Inc.	Sale(S)	523,738	$3.26	$1,705,396	Indirect

1-4 of 4 transactions

About South Cone Investments Limited Partnership

South Cone Investments Limited Partnership (SEC CIK 0001876412) files insider reports with the SEC as 10% Owner of Rani Therapeutics Holdings, Inc. (RANI).

Signal8 holds 2 ownership filings by South Cone Investments Limited Partnership, all Form 4s, filed between Oct 17, 2024 and Oct 22, 2025. Those filings report 4 transactions, from Oct 15, 2024 to Oct 21, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on South Cone Investments Limited Partnership's filings is in SANTIAGO, F3.

Recent filings by South Cone Investments Limited Partnership

Oct 21, 2025: Open-market sale of RANI shares (Form 4, code S).
Oct 20, 2025: Open-market sale of RANI shares (Form 4, code S).
Oct 15, 2024: Open-market sales of RANI shares (2 lines, Form 4, code S).

Other insiders filing for Rani Therapeutics Holdings, Inc. (RANI)

Imran Talat, Chief Executive Officer
Javadi Alireza, Chief Technical Officer
Gilson Michelle, Director
IMRAN MIR A, Director
Maestas Nicholas, Chief Financial Officer
McKinley Kate, Chief Business Officer

How to read Form 4 transaction codes